论文信息 - 1311P First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) + chemotherapy (chemo) in Asian patients (pts) with advanced non-small cell lung cancer (NSCLC) from CheckMate 9LA - 字舞流文

1311P First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) + chemotherapy (chemo) in Asian patients (pts) with advanced non-small cell lung cancer (NSCLC) from CheckMate 9LA

Ying Cheng | M. Satouchi | S. Ikeda | T. Hisada | M. Maemondo | T. John | K. Hotta | M. Takeda | H. Kaneda | K. Kasahara | H. Sakai | K. Minato | Y. Nakahara | Y. Misumi | A. Oukessou | H. Zhang | A. Li | Y. Sato | S. Lu